The Prevention of Dementia With Antihypertensive Treatment<subtitle>New Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study</subtitle>
Indexed incrossref
Abstract
Background
After the double-blind, placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial ended in February 1997, randomized patients were offered active study medication for a further period of observation.
Objective
To refine the estimates of the long-term effects of antihypertensive therapy on the incidence of dementia.
Citation impact
893
total citations
- FWCI
- 25.38
- Percentile
- 100%
- References
- 59
Citations per year
Authors
1Topics & keywords
Topics
Keywords
- Hydrochlorothiazide
- Medicine
- Blood pressure
- Nitrendipine
- Enalapril
- Dementia
- Randomization
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- BBayer
- WHWorld Health Organization
- HYHelsingin Yliopisto
- HJHelsingin ja Uudenmaan Sairaanhoitopiiri
- ISInternational Society of Hypertension
- ECEuropean Commission
- UOUniversity of Aberdeen
- INInstitut National de la Santé et de la Recherche Médicale
- FNFonds National de la Recherche Luxembourg
- HUHebrew University of Jerusalem
- UDUniversidad de Granada